1. Home
  2. TYRA vs YEXT Comparison

TYRA vs YEXT Comparison

Compare TYRA & YEXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TYRA
  • YEXT
  • Stock Information
  • Founded
  • TYRA 2018
  • YEXT 2006
  • Country
  • TYRA United States
  • YEXT United States
  • Employees
  • TYRA N/A
  • YEXT N/A
  • Industry
  • TYRA Biotechnology: Pharmaceutical Preparations
  • YEXT EDP Services
  • Sector
  • TYRA Health Care
  • YEXT Technology
  • Exchange
  • TYRA Nasdaq
  • YEXT Nasdaq
  • Market Cap
  • TYRA 819.3M
  • YEXT 807.8M
  • IPO Year
  • TYRA 2021
  • YEXT 2017
  • Fundamental
  • Price
  • TYRA $15.91
  • YEXT $6.31
  • Analyst Decision
  • TYRA Strong Buy
  • YEXT Buy
  • Analyst Count
  • TYRA 6
  • YEXT 4
  • Target Price
  • TYRA $30.50
  • YEXT $9.00
  • AVG Volume (30 Days)
  • TYRA 261.4K
  • YEXT 819.0K
  • Earning Date
  • TYRA 03-18-2025
  • YEXT 03-05-2025
  • Dividend Yield
  • TYRA N/A
  • YEXT N/A
  • EPS Growth
  • TYRA N/A
  • YEXT N/A
  • EPS
  • TYRA N/A
  • YEXT N/A
  • Revenue
  • TYRA N/A
  • YEXT $408,973,000.00
  • Revenue This Year
  • TYRA N/A
  • YEXT $6.12
  • Revenue Next Year
  • TYRA N/A
  • YEXT $9.39
  • P/E Ratio
  • TYRA N/A
  • YEXT N/A
  • Revenue Growth
  • TYRA N/A
  • YEXT 0.95
  • 52 Week Low
  • TYRA $12.34
  • YEXT $4.29
  • 52 Week High
  • TYRA $29.60
  • YEXT $8.75
  • Technical
  • Relative Strength Index (RSI)
  • TYRA 52.83
  • YEXT 37.18
  • Support Level
  • TYRA $15.75
  • YEXT $6.39
  • Resistance Level
  • TYRA $17.27
  • YEXT $6.60
  • Average True Range (ATR)
  • TYRA 0.91
  • YEXT 0.25
  • MACD
  • TYRA 0.20
  • YEXT 0.04
  • Stochastic Oscillator
  • TYRA 65.99
  • YEXT 18.55

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology The Company's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNAPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. Its lead product candidate is TYRA 300, an FGFR3 selective inhibitor with an initial focus on patients with metastatic urothelial carcinoma of the bladder and urinary tract (mUC).

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

Share on Social Networks: